Combination of pentoxifylline and steroids in sarcoidosis treatment Source: Eur Respir J 2005; 26: Suppl. 49, 269s Year: 2005
Cyclosporin A is effective for the patients with interstitial pneumonia resistant to steroid therapy Source: Eur Respir J 2004; 24: Suppl. 48, 507s Year: 2004
High-doses glucocorticosteroid treatment in sarcoidosis patients Source: Eur Respir J 2007; 30: Suppl. 51, 118s Year: 2007
Effectiveness of itraconazole and systemic steroids in the treatment of ABPA Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018
Pentoxifylline and reduced doses of steroids combination in pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 110s Year: 2007
Comparative analysis of the efficacy of glucocorticosteroids and antimetabolite drugs in treatment of patients with pulmonary sarcoidosis Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues Year: 2019
Is high-dose glucocorticoid beneficial in COVID-19? Source: Eur Respir J, 57 (4) 2100065; 10.1183/13993003.00065-2021 Year: 2021
Low dose theophylline restores steroid insensitivity in PBMCs of steroid insensitive asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 347s Year: 2004
Biomarker-high patients and steroid responsiveness Source: International Congress 2018 – PG17 Asthma phenotyping Year: 2018
The effectiveness of inhaled steroids as first-line therapy in the treatment of newly detected asthma Source: Eur Respir J 2001; 18: Suppl. 33, 266s Year: 2001
Add on therapy of pure theophylline sollution with systemic corticosteroid is more effective for the treatment of asthma attack Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004
Efficacy and toxicity of azathioprine plus corticosteroids in 32 patients with chronic persistent sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004
Efficacy and safety of levamisole as an immunomodulator in the treatment of drug resistant tuberculosis Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019
Comparison of prednisolone and budesonide in the treatment of pulmonary sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 80s Year: 2005
Safety of corticosteroid therapy in patients with pulmonary sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017
Impact of the combination therapy: inhaled corticosteroid and long-acting beta agonists in the prescription pattern of inhaled corticosteroids Source: Annual Congress 2007 - Respiratory issues in primary care Year: 2007
Pharmacological treatment of severe, therapy-resistant asthma in children: what can we learn from where? Source: Eur Respir J 2011; 38: 947-958 Year: 2011
Steroid resistant asthma Source: Annual Congress 2004 - PG8 - Defining clinical asthma phenotypes: implications for therapy Year: 2004
Idiopathic pulmonary fibrosis: efficacy of complex immunosuppressive therapy by cyclophosphamide and corticosteroids Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009
Evaluation of ocular complications of long-term inhaled steroid use Source: Eur Respir J 2001; 18: Suppl. 33, 97s Year: 2001